Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cyxone explores expanding into new regions to mitigate potential delay in Covid-19 trial completion

Cyxone initiated a clinical trial in Eastern Europe with Rabeximod as a treatment for patients with moderate Covid-19 in January 2021. Approximately 90 patients have been successfully enrolled to date. With the declining number of hospitalized Covid-19 patients in Eastern Europe, Cyxone is now considering opening up trial sites in more countries and has had to push back the projected study readout later than Q3 2021.After discovering that the rheumatoid arthritis drug candidate Rabeximod, could be effective in patients with moderate Covid-19, Cyxone started a Phase 2 clinical trial in

AAK enters formal consultation process regarding production consolidation to further optimize its European bakery business

AAK has entered a formal consultation process with union delegates to carry out a production consolidation and subsequent closure of its site in Merksem, Belgium. The suggested initiative is in line with the company’s strategy to optimize performance within the Bakery segment to improve cost efficiency and increase competitiveness. The production site in Merksem, Belgium, which employs approximately 100 people, is predominantly a bakery fats plant, mainly producing margarines and shortenings for the industrial market in continental Europe. The proposed consolidation implies a transfer of

Enersense has completed the sale of the entire share capital of Värväämö Oy to Citywork – Mika Linnamäki will leave the Management Team

Enersense International PlcStock Exchange Release 30 June 2021 at 9.55 a.m.Enersense International Plc, a provider of zero-emission energy solutions, has today completed the sale of the entire share capital of its subsidiary Värväämö Oy, which offers personnel services for the construction industry, to Citywork Oy. The sale was announced on 6 May 2021. As a result of the transaction, the Staff Leasing business area, part of Enersense’s Smart Industry segment, will be closed down and Mika Linnamäki, who led the business, will leave Enersense's Management Team and the company. “I warmly

UpCloud’s new Head of Sales Erik Rehn will lead the sales transformation towards the SMBs user segment

[Helsinki, Finland, 30.6.2021] UpCloud, a European cloud service provider for small and medium-sized companies, has just announced the appointment of Erik Rehn as its new Head of Sales.UpCloud is delighted to announce Erik Rehn joining the company as its new Head of Sales. As a part of UpCloud’s global team, Erik Rehn will be leading UpCloud's sales and business development strategy towards the company’s key user segments among small and medium-sized businesses as well as looking for new market opportunities.  "Not all companies are able or want to use the biggest cloud providers. Either

CELLINK has been granted its first patent of robotic systems for personalized and automated aesthetic medical procedures

CELLINK has been granted a patent for a unique set of robotic systems for transcutaneous delivery of substances, such as cosmetic or surgical fillers, into patients. This is CELLINK’s first granted patent in the field of personalized and automated aesthetic medical procedures - combining the strengths of 3D bioprinting, biomaterials, robotics, automation, and artificial intelligence to optimally administer substances, such as dermal fillers, into subcutaneous regions to improve aesthetical outcomes in patients. This is one technological example of the power of Bioconvergence. This patent

Vestas wins 219 MW order in the USA

News release from Vestas-American Wind TechnologyPortland, 30 June 2021 Vestas has received an order from an undisclosed customer for two wind projects in the USA totalling 219 MW. One project consists of 26 V150-4.2 MW turbines while the other includes 22 V150-4.2 MW and three V136-4.2 MW turbines, with all turbines delivered in 4.3 MW operating mode. “This order builds on the success that the V150-4.2 MW wind turbine has had both in the USA and globally and cements its position as one of the most applicable large wind turbines in the market,” said Jeff Fuchs, Vice President of

BioStock: CombiGene announces several milestones for CG01

Lund-based gene therapy company CombiGene continues to advance its main project CG01 ahead of the phase I studies scheduled to begin next year. The company is now ready for GMP production of drug substance and has also begun a collaboration with UK-based Neurochase in order to optimise the administration of the candidate.Read the full article at biostock.se: https://www.biostock.se/en/combigene-announces-several-milestones-for-cg01/This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se

Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report January – June 2021. The presentation will be held in English.Time: Thursday 15 July, 2021 at 10.00 a.m. CET.Registration can preferably be done 10-15 minutes before the conference start time on:Sweden dial in number: +46 (0)8 566 184 67International dial in number: +44 (0) 2071 928338Conference name: Vitrolife, conference ID: 1295747Vitrolife participants:Thomas Axelsson, CEOMikael Engblom, CFOThe press release for Vitrolife’s interim report will be released at 8.00 CET on the same

Conversion of shares

According to Beijer Ref AB’s Articles of Association, the owner of a Class A share has the right to request that the share should be converted into Class B share. At the request of shareholders, 360 000 Class A shares have been converted into 360 000 Class B shares. Through the reclassification, the total number of votes in the company decreases. After the conversion, the total number of shares and votes in Beijer Ref amounts to 382 304 070 shares and 633 909 510 votes, respectively. 27 956 160 of these shares are A shares, representing 279 561 600 votes, and 354 347 910 are B shares,

New York City Department of Sanitation to purchase seven Mack® LR Electric models

Volvo Group’s subsidiary Mack Trucks announced today that the New York City Department of Sanitation (DSNY) plans to purchase seven Mack® LR Electric refuse models, which will operate in each of the city’s boroughs. Mack made the announcement during WasteExpo 2021, June 28-30 at the Las Vegas Convention Center.DSNY  took delivery of its first fully electric refuse vehicle, a Mack LR Electric demonstration model, in September 2020 , when it began rigorous real-world

Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical data

Lund, Sweden, June 30, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) and Scandion Oncology (Nasdaq Stockholm: SCOL) today announces promising preclinical data from their ongoing collaboration exploring the anti-tumor effects on drug resistant cancer by combining Scandion Oncology’s drug candidate SCO-101 and Alligator Bioscience’s candidate drug mitazalimab.The collaboration explores the anti-tumor efficacy of the CD40 antibody mitazalimab in combination with SCO-101 as an addition to chemotherapy (FOLFIRINOX) in chemotherapy-resistant preclinical tumor models. The hypothesis is

Atlas Copco’s Q2 report 2021 and invitation to conference call, July 16

Nacka, Sweden, June 30, 2021: Atlas Copco will publish its Q2 results for 2021 on Friday, July 16, at approximately 13:30 PM CEST. A conference call for investors, analysts and media will be held at 14:30 PM CEST.Participating from Atlas Copco will be Mats Rahmström, President and CEO, and Hans Ola Meyer, CFO. The conference call will begin with a short presentation of the report followed by a question-and-answer session. The conference call will be broadcasted live on the web. Please see our website www.atlascopcogroup.com/investor-relations for the webcast link and presentation

Mentice appoints Gunilla Andersson as Chief Financial Officer (CFO)

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on image guided interventions, appoints Gunilla Andersson as CFO, effective September 1[st], 2021. Mentice AB is pleased to announce the appointment of Gunilla Andersson as its CFO. Gunilla will be responsible for finance, accounting, business intelligence and IT.  “I am excited to have Gunilla assume the role as CFO for Mentice, says Göran Malmberg, Mentice CEO, her experience from growth companies in the size bracket above us is very relevant and will be instrumental for

Change in the total number of shares and votes in IRRAS AB

Stockholm, June 30, 2021 - IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that as of 30 June 2021, the total number of shares and votes in IRRAS AB amounts to 79,481,340. The number of shares and votes in IRRAS AB has increased as a result of the registration of 13,200,000 ordinary shares, which i accordance with previously announced information was issued in connection with the directed share issue carried out by the company on 10 June 2021. About IRRASIRRAS is a global medical care

Change in the number of shares and votes in Epiroc AB

Stockholm, Sweden: During June 2021, the number the number of outstanding shares in Epiroc AB decreased to 1 213 738 703 from 2 427 477 406 and the number of votes to 862 763 138.9 from 1 725 526 277.8. The change is the result of the 2:1 share split and redemption resolved by the Annual General Meeting on April 28, 2021, which have now concluded.Following the split and redemption, there are 823 765 854 series A shares in the company and 389 972 849 series B shares, corresponding to the number of shares in Epiroc AB before the share split and redemption. The redemption shares resulting

Scandion Oncology A/S and Alligator Bioscience AB present promising preclinical data

Copenhagen, Denmark, June 30, 2021 – Scandion Oncology (Nasdaq Stockholm: SCOL) and Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced promising preclinical data from their ongoing collaboration exploring the anti-tumor effects on drug resistant cancer by combining Scandion Oncology’s drug candidate SCO-101 and Alligator Bioscience’s candidate drug mitazalimab.The collaboration explores the anti-tumor efficacy of the CD40 antibody mitazalimab in combination with SCO-101 as an addition to chemotherapy (FOLFIRINOX) in chemotherapy-resistant preclinical tumor models. The

Alfa Laval supports Russia’s National Clean Air Initiative

Alfa Laval has won an order to supply heat exchangers to one of the largest copper and nickel producers in Russia. The heat exchangers will recover heat from the smelting process and reuse it for heating purposes. The project is part of the producer’s sustainability program supporting Russia’s National Clean Air initiative.The order comprises compact heat exchangers which will be used for sulphuric acid cooling. The heat that is recovered and reused amounts to 150 MW. The energy-efficient process will also enable a 45 percent decrease in emissions from the plant. “Energy efficiency is

Sitowise Group Plc issues 34,012 own shares in a directed issue

Sitowise Group Plc                                                  Stock Exchange Release                                       30 June 2021 at 9:25 a.m. Sitowise Group Plc issues 34,012 own shares in a directed issue On 29 June 2021, the Board of Directors of Sitowise Group Plc ("Sitowise") has decided, by virtue of the authorisation granted by the unanimous resolution of the shareholders on 3 March 2021, to issue in a directed issue 34,012 own Sitowise shares (the "Shares"), that the Board of Directors of Sitowise issued to the company itself earlier the same day. The number of

Integrum AB appoints Magnus Lindholm M.Sc., Mechanical Engineering, as R&D Manager.

Integrum, a leading provider of innovative solutions for bone-anchored prosthetics announces the appointment of Magnus Lindholm as Manager of the Research and Development department. Magnus has joined Integrum with more than 20 years of experience within Research and Development from several different industries, and since 2007, his focus has been the Healthcare sector. As Global Project Manager at Mölnlycke Health Care, he led teams in launch projects within the Wound Care area; taking products from early concept to market launch. As Manager for the R&D team at Integrum, Magnus

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Proposed Firm Placing and Placing and Open Offer

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NOTHING HEREIN SHALL BE CONSTRUED AS AN OFFER, INVITATION OR RECOMMENDATION TO PURCHASE, SELL OR SUBSCRIBE FOR ANY SECURITIES IN ANY JURISDICTION AND NEITHER THIS

FlixBus chooses Gasum’s biogas for their Stockholm to Oslo route – Renewable biogas allows bus companies to reduce their emissions immediately

Gasum has partnered with FlixBus to supply renewable biogas for its new bus operating between the capitals of Sweden and Norway. The new gas-powered bus supports both FlixBus’ and Sweden’s and Norway’s goals in emission reductions.Gasum has initiated a partnership with FlixBus on supplying liquefied biogas (LBG) for its new gas-powered bus operating between Stockholm, Sweden and Oslo, Norway. The bus is a Scania and it will start operating the route in the beginning of July. As a 100% renewable fuel, biogas perfectly supports FlixBus’ climate conscious strategy. FlixBus’ owner

Envirotainer Greets China Airlines as the latest airline to approve the new Releye® RLP container

Stockholm, June 30[th], 2021 - Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Airlines has approved the Envirotainer Releye® RLP for usage on their aircrafts. With this approval, China Airlines can now transport the Releye® RLP on their full network reaching over 115 airports across the world, increasing the capacity to meet demand for temperature-controlled and fully connected ULD solutions.The Envirotainer Releye® RLP is a LD11-sized unit with a unique air flow technology for maximum temperature

Number of shares and votes in Oncopeptides

Stockholm — June 30, 2021 — Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the number of shares and votes in Oncopeptides has changed due to the exercise of warrants under the company’s incentive program.Through the exercise of warrants under the company’s incentive program, the number of outstanding shares and votes has increased by 206,986 from 75,084,855 to 75,291,841. The share capital has increased by approximately SEK 22,998 from SEK 8,342,762 to SEK 8,365,760.  For further information, please contact: Rolf Gulliksen, Global Head of Corporate Communications,

There are no items matching the current filter
There are no more items matching the current filter
Back to top